Science Explorer Interactive view Map
Company · Rehovot · Israel

Vyne Therapeutics (Israel)

vynetherapeutics.comROR OpenAlex
Research works
19
▲ 400% vs 2013–17
Citations
351
18.2 per fractional work
Top-10% rate
3.0%
record average 16.5%
Open access
61%
world 28%

Not ranked overall: Vyne Therapeutics (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.30× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 10.81× its world share, 1 worksImmunology and Micro…Neuroscience: 6.64× its world share, 1 worksNeuroscienceComputer Science: 0.15× its world share, 0 worksComputer ScienceEngineering: 0.39× its world share, 0 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMedicine: 2.78× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.8×. Every wedge is a field page.

Which research topics does Vyne Therapeutics (Israel) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immunotherapy and Immune Responses, Functional Brain Connectivity Studies and Liver Diseases and Immunity.

CAR-T cell therapy research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksFunctional Brain Connect…0Functional Brain Connectivity Studies: 0 fractional worksLiver Diseases and Immun…0Liver Diseases and Immunity: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksPediatric Hepatobiliary …0Pediatric Hepatobiliary Diseases and Treatments: 0 fractional worksCell Adhesion Molecules Research: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksProtease and Inhibitor Mechanisms: 0 fractional works
OncologyImmunologyCognitive NeuroscienceHepatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Immunotherapy and Immune Responses Immunology 1 works
  3. 3 Functional Brain Connectivity Studies Cognitive Neuroscience 0 works
  4. 4 Liver Diseases and Immunity Hepatology 0 works
  5. 5 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Pediatric Hepatobiliary Diseases and Treatments Surgery 0 works
  8. 8 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  9. 9 Ubiquitin and proteasome pathways Molecular Biology 0 works
  10. 10 Protease and Inhibitor Mechanisms Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.8%not open39.2%

World: 28% of research is openly available.

with international co-authors34.3%domestic only65.7%

World: 19% is written across borders.

How has Vyne Therapeutics (Israel)'s research output changed?

Output in 2018–2022 was 400% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rehovot

All research institutions in Rehovot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.